AMSF vs NFBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMSF exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor financial health. The stock is currently trading at $30.74, which is a premium to both its Graham Number ($27.06) and its growth-based Intrinsic Value ($17.01). While revenue growth remains positive, earnings are declining (-8.50% YoY) and the company has failed to beat earnings estimates in the last four consecutive quarters. This fundamental deterioration is mirrored by a 0/100 technical trend and bearish insider activity from the CFO.
NFBK exhibits a stable but mediocre Piotroski F-Score of 4/9, reflecting a company in a transitional health phase. While the Graham Number ($2.73) and Intrinsic Value ($0.14) suggest extreme undervaluation or formula mismatch for a banking entity, the Price/Book ratio of 0.83 indicates the stock is trading below its accounting value. Strong YoY EPS growth (+73.7%) and a reasonable Forward P/E of 9.08 contrast sharply with a distressed trailing P/E and an unsustainable dividend payout ratio. The divergence between the 1-year price surge (+49%) and the bearish technical trend score (10/100) suggests a potential peak or imminent correction.
Compare Another Pair
Related Comparisons
AMSF vs NFBK: Head-to-Head Comparison
This page compares AMERISAFE, Inc. (AMSF) and Northfield Bancorp, Inc. (NFBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.